NRC Health (NRC) earnings
NRC earnings moved a median of -0.08% by the close. Quarterly and annual NRC reports and results, each read against the price at its own news timestamp. Back to the NRC overview →
25 measured NRC earnings events.
Where these NRC earnings landedvs 24 measured NRC earnings reactions
| Middle 50% of NRC earnings reactions | -3.49% to +2.25% |
|---|---|
| Median reaction (to close) | -0.08% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 NRC earnings events with a measured close landed between -3.49% and +2.25%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q NRC HEALTH For: Jun 30 | SEC filing · Form 10-Q | -0.05% | +0.05% | |
| NRC Health Announces Second Quarter 2026 Results | Press release | +1.11% | -18.95% | |
| Form 10-Q NRC HEALTH For: Mar 31 | SEC filing · Form 10-Q | — | -2.35% | |
| Form 10-K/A NRC HEALTH For: Dec 31 | SEC filing · Form 10-K | -3.71% | +2.16% | |
| NRC Health Announces First Quarter 2026 Results | Press release | -3.71% | +2.16% | |
| Form 10-K NATIONAL RESEARCH CORP For: Dec 31 | SEC filing · Form 10-K | +0.93% | +9.18% | |
| NRC Health Announces Fourth Quarter 2025 Results | Press release | -13.08% | -17.86% | |
| Form 10-Q NATIONAL RESEARCH CORP For: Sep 30 | SEC filing · Form 10-Q | +0.28% | +2.51% | |
| NRC Health Announces Third Quarter 2025 Results | Press release | +11.02% | +15.92% | |
| Form 10-Q NATIONAL RESEARCH CORP For: Jun 30 | SEC filing · Form 10-Q | — | +2.23% | |
| NRC Health Announces Second Quarter 2025 Results | Press release | +0.00% | — | |
| Form 10-Q NATIONAL RESEARCH CORP For: Mar 31 | SEC filing · Form 10-Q | -1.16% | -5.53% | |
| NRC Health Announces First Quarter Results | Press release | +2.28% | +10.52% | |
| Form 10-K NATIONAL RESEARCH CORP For: Dec 31 | SEC filing · Form 10-K | +0.30% | +1.41% | |
| National Research Corporation Announces Fourth Quarter Results | Press release | -5.40% | -11.52% | |
| Form 10-Q NATIONAL RESEARCH CORP For: Sep 30 | SEC filing · Form 10-Q | -0.16% | +0.44% | |
| National Research Corporation Announces Third Quarter Results | Press release | +0.44% | +2.29% | |
| Form 10-Q NATIONAL RESEARCH CORP For: Jun 30 | SEC filing · Form 10-Q | -0.20% | -0.23% | |
| National Research Corporation Announces Second Quarter Results | Press release | +0.00% | -8.78% | |
| Form 10-Q NATIONAL RESEARCH CORP For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -2.81% | |
| National Research Corporation Announces First Quarter Results | Press release | -2.29% | -16.73% | |
| National Research Corporation to Broadcast Its First Quarter 2024 Conference Call Live on the Internet | Press release | -1.81% | +4.16% | |
| Form 10-K NATIONAL RESEARCH CORP For: Dec 31 | SEC filing · Form 10-K | +0.16% | -0.21% | |
| Form 10-Q NATIONAL RESEARCH CORP For: Sep 30 | SEC filing · Form 10-Q | +0.77% | -1.98% | |
| National Research Corporation Announces Third Quarter 2023 Results | Press release | +0.00% | -1.56% |
Keep exploring
More NRC: analyst actions → · SEC filings → · NRC overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sunshine Biopharma Inc. - Common stock (SBFM) | 178 | -0.33% | 45% |
| Cardax, Inc. (CDXI) | 177 | 0.00% | 13% |
| Palatin Technologies, Inc. (PTN) | 177 | -0.54% | 45% |
| Rafael Holdings, Inc. Class B (RFL) | 176 | 0.00% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.